The abstract is read at the publisher; the summary is JClub's.
In a Mayo Clinic retrospective cohort of Lennox-Gastaut syndrome patients, DBS+VNS achieved a higher 24-month median seizure reduction rate (81%) than DBS alone (43%) or VNS alone (50%).
- Why it matters: Comparative evidence for vagus nerve stimulation versus deep brain stimulation in LGS is limited, and it is unclear whether combining neuromodulation improves seizure outcomes.
- What they did: The study reviewed 40 LGS patients treated with VNS and/or DBS from 2005–2024, assessing seizure frequency at 6, 12, and 24 months and defining responders as ≥50% reduction.
- The result: At 24 months, median seizure reduction was comparable for VNS (50%) and the overall DBS cohort (59%, p=0.54), but differed across the three arms (p=0.027), with DBS+VNS outperforming DBS alone (p adj=0.027) and VNS alone (p adj=0.048).
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.